Under the Liberalised and Accelerated Phase 3 Strategy of the National COVID-19 Vaccination programme, the vaccine manufacturers would supply 50 per cent of their doses to the Centre while rest can be given to states and in the open market, a report said.
It was decided that the manufactures will have to release their price list in advance for the 50 per cent vaccines earmarked for the States and the open market. This channel will be open for adults but healthcare and frontline workers and all people above 45 years of age can continue to receive the vaccine free of cost at government-operated vaccination centres.
Also, all indigenously produced vaccines will be distributed equally between the Centre and States. The stock and availability of vaccines will have to provided by all centre on a real-time basis.
In another way, the government paved the way for certain foreign vaccines approved by bodies of the European Union or the US for inoculation in India. However, these vaccines will be provided only in other-than government channels like open markets.
India launched the vaccination programme in the middle of January in phases for health care and frontline workers and people above 45 years of age. Two vaccines -- indigenously developed Covaxin and UK’s AstraZeneca vaccine called Covishield -- are being administered currently.
So far 12,38,52,566 vaccine doses have administered, as per the Ministry of Health and Family Welfare. (UNI)